Ketoskin Cream contains Ketoconazole 2% w/w, an imidazole antifungal agent effective in the treatment of various superficial fungal infections. Ketoconazole acts by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. This topical formulation is indicated for the management of dermatophytosis, candidiasis, pityriasis versicolor, and seborrheic dermatitis. Ketoskin Cream is applied once or twice daily to the affected area, ensuring the skin is clean and dry prior to application. The duration of treatment varies depending on the infection type and clinical response but typically ranges from 2 to 4 weeks. Common adverse effects are generally mild and may include local irritation, burning sensation, or erythema at the site of application. Ketoskin Cream should be used with caution in patients with known hypersensitivity to ketoconazole or any of the cream’s excipients. It is contraindicated in mucosal areas and open wounds. Patients are advised to avoid contact with eyes and mucous membranes. Ketoskin Cream offers a targeted antifungal therapy option with a favorable safety profile for the effective management of superficial fungal infections.